GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BioMerieux SA (LTS:0RUG) » Definitions » Accounts Payable

BioMerieux (LTS:0RUG) Accounts Payable : €272 Mil (As of Dec. 2024)


View and export this data going back to 2007. Start your Free Trial

What is BioMerieux Accounts Payable?

BioMerieux's Accounts Payable for the quarter that ended in Dec. 2024 was €272 Mil.

BioMerieux's quarterly Accounts Payable declined from Dec. 2023 (€265 Mil) to Jun. 2024 (€216 Mil) but then increased from Jun. 2024 (€216 Mil) to Dec. 2024 (€272 Mil).

BioMerieux's annual Accounts Payable declined from Dec. 2022 (€269 Mil) to Dec. 2023 (€265 Mil) but then increased from Dec. 2023 (€265 Mil) to Dec. 2024 (€272 Mil).


BioMerieux Accounts Payable Historical Data

The historical data trend for BioMerieux's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioMerieux Accounts Payable Chart

BioMerieux Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 207.10 239.50 269.40 265.10 272.40

BioMerieux Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 269.40 243.50 265.10 215.70 272.40

BioMerieux Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


BioMerieux Accounts Payable Related Terms

Thank you for viewing the detailed overview of BioMerieux's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


BioMerieux Business Description

Traded in Other Exchanges
Address
Marcy l’Etoile, Lyon, FRA, 69280
BioMérieux designs, develops, and manufactures a broad portfolio of in vitro diagnostics for detecting disease-causing pathogens and contamination. The company operates in four segments: molecular biology (34% of 2023 sales), microbiology (39%), immunoassays (10%), and industrial applications (about 17%). The Amercas account for the largest portion of the firm's revenue (45%), followed by Europe, the Middle East, and Africa (31%), and Asia-Pacific (16%). BioMérieux is headquartered in Marcy-l'Etoile, France.

BioMerieux Headlines

No Headlines